Tag: Eli Lilly and Co
Pfizer weight loss pill moves forward as once-daily version
Sopa Images | Lightrocket | Getty ImagesPfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, a [...]
FTC to sue PBMs over drug prices including insulin
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled "Fiscal Ye [...]
FDA approves Eli Lilly Alzheimer’s drug donanemab
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.Scott Olson | [...]
Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility
Novo Nordisk's new manufacturing facility in Clayton, North Carolina.Courtesy: Novo NordiskNovo Nordisk on Monday said it will spend $4.1 billion to b [...]
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing di [...]
Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 20 [...]
FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]
Ro launches GLP-1 supply tracker to help patients navigate shortages
GLP-1 Supply Tracker from Ro. Courtesy: RoTelehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight lo [...]
Eli Lilly invests to increase Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersEli Lilly on Frid [...]
This up-and-coming cancer treatment could be a $25 billion market opportunity
Skynesher | E+ | Getty ImagesBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a "mas [...]
Roche weight loss drug shows promising results in early trial
A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024.Bloomberg | Getty ImagesRoche on Thursday said its experi [...]
Wegovy patients maintain weight loss for 4 years: Novo Nordisk study
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | ReutersPatients taking Novo Nordisk's obe [...]
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois.Scott Olson | Getty Ima [...]
Amgen scraps experimental weight loss pill, moves forward with injection
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.Mario Tama | Getty ImagesAmgen on Thursday said i [...]
Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled inv [...]